Literature DB >> 10170291

Economic advantages of breast-feeding in an HMO: setting a pilot study.

C Hoey1, J L Ware.   

Abstract

We performed a pilot study on newborns randomly chosen from term singleton deliveries born to mothers in an HMO group between September 1992 and August 1993. Breast-fed infants were breast-feeding at 6 months (n = 41), whereas bottle-fed infants were bottle-fed from birth (n = 107), Medical care and costs for the first 12 months were retrospectively analyzed, including office visits, drug prescriptions, and hospitalizations. Both groups had similar numbers of office visits and pharmacy costs. Breast-fed infants had fewer inpatient admissions (0.13 vs. 0.20 discharges per 1,000 babies), and their average total medical costs were $200 less than those of bottle-fed infants. Extrapolating to the total number of deliveries during this period, an increase in breast-feeding from the current rate (17%) to the Healthy People 2000 goal (50%) could save up to $140,000 annually.

Entities:  

Mesh:

Year:  1997        PMID: 10170291

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  3 in total

Review 1.  The paradox of breastfeeding-associated morbidity among late preterm infants.

Authors:  Jill V Radtke
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2011 Jan-Feb

2.  Cost of individual peer counselling for the promotion of exclusive breastfeeding in Uganda.

Authors:  Lumbwe Chola; Lungiswa Nkonki; Chipepo Kankasa; Jolly Nankunda; James Tumwine; Thorkild Tylleskar; Bjarne Robberstad
Journal:  Cost Eff Resour Alloc       Date:  2011-06-29

3.  A study to prolong breastfeeding duration: design and rationale of the Parent Infant Feeding Initiative (PIFI) randomised controlled trial.

Authors:  Bruce R Maycock; Jane A Scott; Yvonne L Hauck; Sharyn K Burns; Suzanne Robinson; Roslyn Giglia; Anita Jorgensen; Becky White; Annegrete Harries; Satvinder Dhaliwal; Peter A Howat; Colin W Binns
Journal:  BMC Pregnancy Childbirth       Date:  2015-08-01       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.